Mark Bagarazzi, Chief Medical Officer at INOVIO PHARMACEUTICALS, INC. (INO), bought 60,000 shares at $0.56 ($34K) on 2013-04-16, disclosed to the SEC on 2013-04-16.
Open-market purchase of $34k INO by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.